Prime Medicine, Inc. - Common Stock — Stato Patrimoniale (NASDAQ:PRME) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi

Trimestrale Annuale

Totale attivo 360.31 M193.85 M297.51 M342.73 M Totale passività 44.04 M60.78 M144.36 M221.87 M Patrimonio netto totale 316.27 M133.07 M153.15 M120.87 M Totale passività e patrimonio netto 360.31 M193.85 M297.51 M342.73 M Debito totale ———— Indebitamento netto ————

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

Notizie

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Prime Medicine nomina Svetlana Makhni come direttore finanziario

Prime Medicine nomina Svetlana Makhni direttore finanziario

Prime Medicine nomina Svetlana Makhni come CFO

Prime Drink Group annuncia posizionamento privato fino a 4 milioni di dollari canadesi

Prime Medicine, Inc. (PRME) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Citizens conferma il rating su Prime Medicine per il percorso PM359

Citizens reiterates Prime Medicine stock rating on PM359 pathway

Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates